Published in Ann Nucl Med on December 01, 2004
Hidden sentinel node in cutaneous melanoma. Arch Plast Surg (2013) 0.75
Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study. Cancer (2004) 4.54
Clinical importance of estrogen receptor-beta evaluation in breast cancer patients treated with adjuvant tamoxifen therapy. J Clin Oncol (2008) 2.90
One-step nucleic acid amplification for intraoperative detection of lymph node metastasis in breast cancer patients. Clin Cancer Res (2007) 2.36
Sentinel node tumour burden quantified based on cytokeratin 19 mRNA copy number predicts non-sentinel node metastases in breast cancer: molecular whole-node analysis of all removed nodes. Eur J Cancer (2012) 2.01
Quantitative transcriptional control of ErbB receptor signaling undergoes graded to biphasic response for cell differentiation. J Biol Chem (2006) 1.99
Efficient fixation of carbon dioxide by hypervalent organobismuth oxide, hydroxide, and alkoxide. Angew Chem Int Ed Engl (2008) 1.68
The prevalence of intrinsic subtypes and prognosis in breast cancer patients of different races. Breast (2007) 1.64
Hemodynamics in vasculogenic mimicry and angiogenesis of inflammatory breast cancer xenograft. Cancer Res (2002) 1.64
Molecular detection of lymph node metastases in breast cancer patients: results of a multicenter trial using the one-step nucleic acid amplification assay. Clin Cancer Res (2009) 1.52
A possible contribution of endothelial CCN1 downregulation due to Fli1 deficiency to the development of digital ulcers in systemic sclerosis. Exp Dermatol (2015) 1.42
Late toxicity after definitive concurrent chemoradiotherapy for thoracic esophageal carcinoma. Int J Radiat Oncol Biol Phys (2009) 1.40
Deaths within 12 months after (125)I implantation for brachytherapy of prostate cancer: an investigation of radiation safety issues in Japan (2003-2010). Brachytherapy (2011) 1.38
Plasma concentration profiles of ketamine and norketamine after administration of various ketamine preparations to healthy Japanese volunteers. Biopharm Drug Dispos (2003) 1.29
Ipsilateral breast tumor recurrence (IBTR) after breast-conserving treatment for early breast cancer: risk factors and impact on distant metastases. Cancer (2006) 1.28
Flare-up of dermatomyositis along with recurrence of breast cancer. Breast J (2007) 1.25
Genome-wide gene-expression profiles of breast-cancer cells purified with laser microbeam microdissection: identification of genes associated with progression and metastasis. Int J Oncol (2004) 1.20
A case of carcinosarcoma of the breast. Breast Cancer (2005) 1.18
Analysis of ipsilateral breast tumor recurrences after breast-conserving treatment based on the classification of true recurrences and new primary tumors. Breast Cancer (2005) 1.10
Pharmacokinetic and pharmacodynamic analysis of systemic effect of topically applied timolol maleate ophthalmic gelling vehicle (Rysmon TG). Curr Eye Res (2005) 1.09
High-level expression of single-chain Fv-Fc fusion protein in serum and egg white of genetically manipulated chickens by using a retroviral vector. J Virol (2005) 1.08
General rules for clinical and pathological recording of breast cancer 2005. Breast Cancer (2005) 1.08
Hepatic resection for metastatic breast cancer: prognostic analysis of 34 patients. World J Surg (2005) 1.08
Clinicopathologic study of 53 metaplastic breast carcinomas: their elements and prognostic implications. Hum Pathol (2010) 1.06
Metastatic breast carcinoma of the abdominal wall muscle: a case report. Breast Cancer (2012) 1.06
Receptor occupancy theory-based analysis of interindividual differences in antiemetic effects of 5-HT3 receptor antagonists. Int J Clin Oncol (2009) 1.05
Malignant transformation of breast fibroadenoma to malignant phyllodes tumor: long-term outcome of 36 malignant phyllodes tumors. Breast Cancer (2011) 1.03
Tumor-infiltrating endothelial cells and endothelial precursor cells in inflammatory breast cancer. Int J Cancer (2002) 1.03
Transforming growth factor B1 T29C polymorphism and breast cancer risk in Japanese women. Breast Cancer (2003) 1.00
IL12RB2 and ABCA1 genes are associated with susceptibility to radiation dermatitis. Clin Cancer Res (2008) 0.99
High prevalence of HER-2/neu and p53 overexpression in inflammatory breast cancer. Breast Cancer (2006) 0.99
Analysis of pharmacological effects of drugs used for treatment of urinary disturbance based on anticholinergic and smooth muscle-relaxing effects. Biol Pharm Bull (2007) 0.99
Clinicopathological analyses of triple negative breast cancer using surveillance data from the Registration Committee of the Japanese Breast Cancer Society. Breast Cancer (2009) 0.99
Molecular characterization of apocrine carcinoma of the breast: validation of an apocrine protein signature in a well-defined cohort. Mol Oncol (2009) 0.99
Detection of occult invasion in ductal carcinoma in situ of the breast with sentinel node metastasis. Cancer Sci (2013) 0.98
Clinicopathological significance of invasive micropapillary carcinoma component in invasive breast carcinoma. Pathol Int (2011) 0.97
Four-dimensional measurement of the displacement of internal fiducial and skin markers during 320-multislice computed tomography scanning of breast cancer. Int J Radiat Oncol Biol Phys (2012) 0.97
Significance of (18)F-2-deoxy-2-fluoro-glucose accumulation in the stomach on positron emission tomography. Ann Nucl Med (2009) 0.97
Sivelestat sodium hydrate improves septic acute lung injury by reducing alveolar dysfunction. Res Commun Mol Pathol Pharmacol (2006) 0.96
Favourable long-term results after surgical removal of lung metastases of breast cancer. Breast Cancer Res Treat (2007) 0.96
Aberrant expression of tumor suppressors CADM1 and 4.1B in invasive lesions of primary breast cancer. Breast Cancer (2011) 0.95
Dosimetric consideration of individual 125I source strength measurement and a large-scale comparison of that measured with a nominal value in permanent prostate implant brachytherapy. Radiat Med (2006) 0.95
Bone metabolic markers as gauges of metastasis to bone: a review. Ann Nucl Med (2002) 0.94
Rewritable phosphorescent paper by the control of competing kinetic and thermodynamic self-assembling events. Nat Mater (2005) 0.94
Possible use of combination chemotherapy with mitomycin C and methotrexate for metastatic breast cancer pretreated with anthracycline and taxanes. Breast Cancer (2009) 0.94
Ductal carcinoma in situ and sentinel lymph node metastasis in breast cancer. World J Surg Oncol (2010) 0.93
Cross-sectional analysis of germline BRCA1 and BRCA2 mutations in Japanese patients suspected to have hereditary breast/ovarian cancer. Cancer Sci (2008) 0.93
Mutation of epidermal growth factor receptor is associated with MIG6 expression. FEBS J (2009) 0.93
Cancer of unknown primary site: a review of 28 cases and the efficacy of cisplatin/docetaxel therapy at a single institute in Japan. Acta Med Okayama (2010) 0.92
Cardiac-sparing radiotherapy for the left breast cancer with deep breath-holding. Jpn J Radiol (2009) 0.92
Meta-analysis of five studies on tegafur plus uracil (UFT) as post-operative adjuvant chemotherapy for breast cancer. Oncology (2003) 0.91
Effect of the single CYP2C9*3 allele on pharmacokinetics and pharmacodynamics of losartan in healthy Japanese subjects. Eur J Clin Pharmacol (2003) 0.91
Theory based analysis of anti-inflammatory effect of infliximab on Crohn's disease. Drug Metab Pharmacokinet (2007) 0.91
Predictors of successful hepatic resection: prognostic usefulness of hepatic asialoglycoprotein receptor analysis. World J Surg (2002) 0.91
Aberrant axonal projections from mammillary bodies in Pax6 mutant mice: possible roles of Netrin-1 and Slit 2 in mammillary projections. J Neurosci Res (2009) 0.90
Correlation of allelic losses and clinicopathological factors in 504 primary breast cancers. Breast Cancer (2002) 0.90
Present state of and problems with core needle biopsy for non-palpable breast lesions. Breast Cancer (2006) 0.90
High levels of DJ-1 protein in nipple fluid of patients with breast cancer. Cancer Sci (2012) 0.90
Assessment of hormone receptor status in breast cancer. Pathol Int (2007) 0.89
A clinico-pathological study on cancer in sclerosing adenosis. Breast Cancer (2013) 0.89
Spontaneous " healing" of breast cancer. Breast Cancer (2005) 0.89
Production of chimeric monoclonal antibodies by genetically manipulated chickens. J Biotechnol (2009) 0.88
IgG4-related sclerosing disease of the breast successfully treated by steroid therapy. Breast Cancer (2010) 0.88
Phenylboronic acid-installed polymeric micelles for targeting sialylated epitopes in solid tumors. J Am Chem Soc (2013) 0.88
Expression profiling to predict postoperative prognosis for estrogen receptor-negative breast cancers by analysis of 25,344 genes on a cDNA microarray. Cancer Sci (2004) 0.88
Estrogen receptor-α directly regulates sensitivity to paclitaxel in neoadjuvant chemotherapy for breast cancer. Breast Cancer Res Treat (2011) 0.87
Ki-67 evaluation at the hottest spot predicts clinical outcome of patients with hormone receptor-positive/HER2-negative breast cancer treated with adjuvant tamoxifen monotherapy. Breast Cancer (2013) 0.87
Phosphorescent organogels via "metallophilic" interactions for reversible RGB-color switching. J Am Chem Soc (2005) 0.87
Incidence and prediction of invasive disease and nodal metastasis in preoperatively diagnosed ductal carcinoma in situ. Cancer Sci (2014) 0.87
Classification of ipsilateral breast tumor recurrence after breast-conserving therapy: new primary cancer allows a good prognosis. Breast Cancer (2005) 0.87
Green Urine Discoloration due to Propofol Infusion: A Case Report. Case Rep Emerg Med (2011) 0.86
Distance learning: a strategy for improving incontinence care in nursing homes. Gerontologist (2009) 0.86
Post-operative breast cancer patients diagnosed with skeletal metastasis without bone pain had fewer skeletal-related events and deaths than those with bone pain. BMC Cancer (2010) 0.86
A pilot study of wider use of accelerated partial breast irradiation: intraoperative margin-directed re-excision combined with sole high-dose-rate interstitial brachytherapy. Breast Cancer (2006) 0.85